Searched for
ANTIHYPERTENSIVE MEDICATIONS
Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...- Private hospital ordered to pay Rs 34 lakh compensation for delaying ICU treatment over consentWockhardt Hospitals in Nashik must pay ₹34 lakh to the father of a deceased patient. The consumer commission found the hospital negligent f...
- You can control both BP and diabetes with one diet. New study offers a game-changing fixA new study published in JAMA Internal Medicine introduces the DASH4D diet—a modified DASH plan tailored for people with type 2 diabetes. T...
- Alembic Pharmaceuticals gets USFDA nod for generic hypertension treatment capsulesAlembic Pharmaceuticals Ltd has secured final approval from the USFDA for its generic Diltiazem Hydrochloride extended-release capsules. Th...
- Alembic Pharma gets USFDA nod for generic hypertension treatment capsulesAlembic Pharmaceuticals has received USFDA final approval for its generic Diltiazem Hydrochloride extended-release capsules in strengths of...
- Heatwave ignites surge in chronic therapy demandRising temperatures across various regions of India are driving increased demand for medications aimed at managing chronic conditions. This...
- Cutting down on salt intake as good as medicines for high BP: StudyA recent study published in JAMA suggests that reducing salt intake can be as effective as commonly prescribed medications for managing hig...
- JB Pharma Q1 Results: Net profit surges 35% YoY to Rs 142 croreDomestic business revenue grew 17% YoY to Rs 489 crores in Q1FY24, despite sales for the acute business being impacted due to the delayed m...
- Medication for high blood pressure can improve Covid survival rate, reduce severity of infectionThe medicines can improve Covid-19 survival rates, particularly in patients with hypertension.
- Blood pressure drugs may improve Covid-19 survival rates: StudyMedication for high blood pressure may improve Covid-19 survival rates, and reduce the severity of novel coronavirus infection, particularl...
- Aurobindo recalls hypertensive drug in US citing cancer riskScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said.
- US Medicare could have saved $1 billion by substituting branded drugs, says studyThe revelation is significant for India since Indian pharma companies supply 40 per cent of generic drugs consumed in the US.
- Hypertensed? Here's how you can keep your coolA healthy diet and a proper lifestyle are musts in dealing with hypertension.
- Cadila Healthcare recalls blood pressure drug in the USThe recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc.
- Wockhardt recalls 8,712 bottles of hypertension drug in US marketWockhardt is recalling over 8,000 bottles of anti-hypertension drug Metoprolol Succinate extended-release tablets following failure of a di...
- Cancer medicines for as low as Rs 1,000 a month on wayTata Memorial Hospital’s doctors are working on alternatives that could cost less than Rs 1,000 a month.
- Ranbaxy to market Daiichi’s products in MexicoDaiichi Sankyo said its Indian arm Ranbaxy Laboratories will start selling its original products in Mexico as part of its strategy to lever...
- Ranbaxy to launch anti-hypertensive drug in AfricaRanbaxy Laboratories will launch parent company Daiichi Sankyo’s anti-hypertensive drug, Olmesartan Medoxomil, in six African countries und...
- Ranbaxy to market Daiichi's products in RomaniaDrug firm Ranbaxy Laboratories today said its Romanian arm will market Daiichi Sankyo's drug Evista, used in treatment of osteoporosis, in ...
- Medicines likely to get cheaper by 10-70%Prices of costly “essential” medicines are set to fall by 30% to 70% and that of low end brands may fall by 10% to 30%, once the new drug p...
Load More
